Research Grant Call Invitation Information for Pantothenate Kinase-associated Neurodegeneration (PKAN)

The research objectives for the PKAN 2026 Collaborative Grant Call are to support high-quality, translational research that advances meaningful therapeutic progress for individuals living with PKAN. 

Proposed studies may address key barriers to translation, such as delivery, safety, dosing, manufacturing readiness, or the generation of proof-of-concept data, and should demonstrate a rationale for how the work may improve symptoms, slow disease progression, or alter the course of PKAN.

Funding: $100,000 total 

Duration: 1-2 years

Research Authority due date: 19.2.26

LOI (required) due date: 28.2.26

Full proposal due date: 30.5.26